Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 4
1992 3
1993 5
1994 2
1995 3
1996 2
1997 5
1998 3
1999 5
2000 2
2001 3
2002 1
2003 3
2004 3
2006 4
2007 2
2008 3
2009 3
2010 4
2011 2
2012 3
2013 4
2014 4
2015 6
2016 11
2017 14
2018 7
2019 12
2020 8
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Zaromskis
Page 1
Pharmacotherapy for social anxiety disorder (SAnD).
Williams T, Hattingh CJ, Kariuki CM, Tromp SA, van Balkom AJ, Ipser JC, Stein DJ. Williams T, et al. Cochrane Database Syst Rev. 2017 Oct 19;10(10):CD001206. doi: 10.1002/14651858.CD001206.pub3. Cochrane Database Syst Rev. 2017. PMID: 29048739 Free PMC article. Review.
Treatment with SSRIs and RIMAs was also associated with a reduction in depression symptoms. ...Tolerability of SSRIs was lower than placebo, but absolute withdrawal rates were low.While a small number of trials did report treatment efficacy for benzodiazepines, anticonvuls …
Treatment with SSRIs and RIMAs was also associated with a reduction in depression symptoms. ...Tolerability of SSRIs was lower than p …
Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression.
Lum CT, Stahl SM. Lum CT, et al. CNS Spectr. 2012 Sep;17(3):107-20. doi: 10.1017/s1092852912000594. CNS Spectr. 2012. PMID: 23888494 Review.
MAOIs tend to be underutilized in clinical practice, due in part to misinformation and mythology about their dietary and drug interactions. The new class of reversible monoamine oxidase inhibitors (RIMAs) has shown efficacy in depression, with safety and tolerability compa …
MAOIs tend to be underutilized in clinical practice, due in part to misinformation and mythology about their dietary and drug interactions. …
Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study.
Gadgeel SM, Lukas RV, Goldschmidt J, Conkling P, Park K, Cortinovis D, de Marinis F, Rittmeyer A, Patel JD, von Pawel J, O'Hear C, Lai C, Hu S, Ballinger M, Sandler A, Gandhi M, Fehrenbacher L. Gadgeel SM, et al. Lung Cancer. 2019 Feb;128:105-112. doi: 10.1016/j.lungcan.2018.12.017. Epub 2018 Dec 19. Lung Cancer. 2019. PMID: 30642441 Clinical Trial.
MAOIs to RIMAs in anaesthesia--a literature review.
Hill S, Yau K, Whitwam J. Hill S, et al. Psychopharmacology (Berl). 1992;106 Suppl:S43-5. doi: 10.1007/BF02246234. Psychopharmacology (Berl). 1992. PMID: 1546140 Review.
With the advent of reversible, specific inhibitors of MAO-A (RIMAs) there is less potential for dietary and drug interaction. ...
With the advent of reversible, specific inhibitors of MAO-A (RIMAs) there is less potential for dietary and drug interaction. ...
Risk-benefit assessment of newer versus older monoamine oxidase (MAO) inhibitors.
Lecrubier Y. Lecrubier Y. Drug Saf. 1994 Apr;10(4):292-300. doi: 10.2165/00002018-199410040-00003. Drug Saf. 1994. PMID: 8018301 Review.
Older MAO inhibitors are more effective than TCAs in the treatment of atypical depression, and further studies are needed to confirm if this is true for RIMAs. Long term studies to evaluate the effects of RIMAs on disease recurrence are also required. ...Overall, …
Older MAO inhibitors are more effective than TCAs in the treatment of atypical depression, and further studies are needed to confirm if this …
Leptomeningeal metastasis from solid tumors.
Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV. Thakkar JP, et al. J Neurol Sci. 2020 Apr 15;411:116706. doi: 10.1016/j.jns.2020.116706. Epub 2020 Jan 23. J Neurol Sci. 2020. PMID: 32007755 Review.
A Survey of the Neuro-Oncology Landscape.
Lukas RV, Wu J, Dey M, Buerki RA, Byrne RW, Dohrmann GJ. Lukas RV, et al. J Clin Neurol. 2018 Jan;14(1):8-15. doi: 10.3988/jcn.2018.14.1.8. Epub 2017 Oct 31. J Clin Neurol. 2018. PMID: 29141278 Free PMC article. Review.
What is New in Neuro-oncology?
Thakkar JP, Prabhu VC, Peters KB, Lukas RV. Thakkar JP, et al. Neurol Clin. 2021 Feb;39(1):163-179. doi: 10.1016/j.ncl.2020.09.009. Epub 2020 Nov 7. Neurol Clin. 2021. PMID: 33223081 Review.
Management of glioblastoma in elderly patients.
Young JS, Chmura SJ, Wainwright DA, Yamini B, Peters KB, Lukas RV. Young JS, et al. J Neurol Sci. 2017 Sep 15;380:250-255. doi: 10.1016/j.jns.2017.07.048. Epub 2017 Aug 1. J Neurol Sci. 2017. PMID: 28870580 Free PMC article. Review.
Immunotherapy Against Gliomas: is the Breakthrough Near?
Lukas RV, Wainwright DA, Horbinski CM, Iwamoto FM, Sonabend AM. Lukas RV, et al. Drugs. 2019 Nov;79(17):1839-1848. doi: 10.1007/s40265-019-01203-z. Drugs. 2019. PMID: 31598900 Free PMC article. Review.
114 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page